176 related articles for article (PubMed ID: 35612824)
21. Surgical management of pancreatic neuroendocrine tumors: an introduction.
Hain E; Sindayigaya R; Fawaz J; Gharios J; Bouteloup G; Soyer P; Bertherat J; Prat F; Terris B; Coriat R; Gaujoux S
Expert Rev Anticancer Ther; 2019 Dec; 19(12):1089-1100. PubMed ID: 31825691
[No Abstract] [Full Text] [Related]
22. Renal tumors in tuberous sclerosis complex.
Trnka P; Kennedy SE
Pediatr Nephrol; 2021 Jun; 36(6):1427-1438. PubMed ID: 33006051
[TBL] [Abstract][Full Text] [Related]
23. A single-center experience with pancreatic cystic neuroendocrine tumors.
Khalil A; Ewald J; Marchese U; Autret A; Garnier J; Niccoli P; Piana G; Poizat F; Giovannini M; Delpero JR; Turrini O
World J Surg Oncol; 2020 Aug; 18(1):208. PubMed ID: 32799893
[TBL] [Abstract][Full Text] [Related]
24. What Is the Role of Lymph Node Resections in Small Islet Tumors?
Gangi A; Ferrone CR
Adv Surg; 2023 Sep; 57(1):47-58. PubMed ID: 37536861
[TBL] [Abstract][Full Text] [Related]
25. Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis.
Birnbaum DJ; Gaujoux S; Cherif R; Dokmak S; Fuks D; Couvelard A; Vullierme MP; Ronot M; Ruszniewski P; Belghiti J; Sauvanet A
Surgery; 2014 Jan; 155(1):13-21. PubMed ID: 24238123
[TBL] [Abstract][Full Text] [Related]
26. Pancreatic neuroendocrine tumor in a child with a tuberous sclerosis complex 2 (TSC2) mutation.
Bombardieri R; Moavero R; Roberto D; Cerminara C; Curatolo P
Endocr Pract; 2013; 19(5):e124-8. PubMed ID: 23757617
[TBL] [Abstract][Full Text] [Related]
27. Cystic Pancreatic Neuroendocrine Tumors Represent a Distinct Clinical Entity with Less Aggressive Biological Behaviors.
Cheng Y; Wu D; Wang L; Liu H; Xiong Y; Xu J; Hu S; Zhan H
J Surg Res; 2021 Apr; 260():134-140. PubMed ID: 33340866
[TBL] [Abstract][Full Text] [Related]
28. Tuberous sclerosis complex: diagnostic challenges, presenting symptoms, and commonly missed signs.
Staley BA; Vail EA; Thiele EA
Pediatrics; 2011 Jan; 127(1):e117-25. PubMed ID: 21173003
[TBL] [Abstract][Full Text] [Related]
29. International Validation of a Nomogram to Predict Recurrence after Resection of Grade 1 and 2 Nonfunctioning Pancreatic Neuroendocrine Tumors.
Heidsma CM; van Roessel S; van Dieren S; Engelsman AF; Strobel O; Buechler MW; Schimmack S; Perinel J; Adham M; Deshpande V; Kjaer J; Norlen O; Gill AJ; Samra JS; Mittal A; Hoogwater FJH; Primavesi F; Stättner S; Besselink MG; van Eijck CHJ; Nieveen van Dijkum EJM
Neuroendocrinology; 2022; 112(6):571-579. PubMed ID: 34343138
[TBL] [Abstract][Full Text] [Related]
30. Recurrence and outcomes of non-functional pancreatic neuroendocrine tumours post-resection: an Australian retrospective, multicentre cohort study.
Lim S; Chong L; Peeroo S; Onasanya O; He E; Banting S; Croagh D
ANZ J Surg; 2023 Jan; 93(1-2):160-165. PubMed ID: 36562118
[TBL] [Abstract][Full Text] [Related]
31. Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review.
Dworakowska D; Grossman AB
Endocr Relat Cancer; 2009 Mar; 16(1):45-58. PubMed ID: 18978035
[TBL] [Abstract][Full Text] [Related]
32. Management and outcomes of patients for non-functioning pancreatic neuroendocrine tumours: a multi-institutional analysis.
Du B; Wang X; Zhang W; Tan Q; Wei Y; Shao Z
ANZ J Surg; 2022 Apr; 92(4):787-793. PubMed ID: 34723424
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrine tumor of the pancreas in a patient with tuberous sclerosis: a case report and review of the literature.
Díaz Díaz D; Ibarrola C; Goméz Sanz R; Pérez Hurtado B; Salazar Tabares J; Colina Ruizdelgado F
Int J Surg Pathol; 2012 Aug; 20(4):390-5. PubMed ID: 22169969
[TBL] [Abstract][Full Text] [Related]
34. Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies.
Dumlu EG; Karakoç D; Özdemir A
Int Surg; 2015 Jun; 100(6):1089-97. PubMed ID: 25590518
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
36. [Enucleation of pancreatic tumors: a multiple-center study].
Solodkiy VA; Kriger AG; Akhaladze GG; Goev AA; Goncharov SV; Gorin DS; Zagainov VE; Kuznetsov NS; Kuchin DM; Latkina NV; Lysanyuk MV; Maistrenko NA; Martirosyan TA; Romashchenko PN; Shuinova EA; Yukina MY
Khirurgiia (Mosk); 2023; (2):13-20. PubMed ID: 36748866
[TBL] [Abstract][Full Text] [Related]
37. Update on the Surgical Treatment of Pancreatic Neuroendocrine Tumors.
Jeune F; Taibi A; Gaujoux S
Scand J Surg; 2020 Mar; 109(1):42-52. PubMed ID: 31975647
[TBL] [Abstract][Full Text] [Related]
38. Insulinoma in tuberous sclerosis: An entity not to be missed.
Al Qahtani MS; Bojal SA; Alqarzaie AA; Alqahtani AA
Saudi Med J; 2021 Mar; 42(3):332-337. PubMed ID: 33632913
[TBL] [Abstract][Full Text] [Related]
39. Surgical Management of Pancreatic Neuroendocrine Tumors.
Clancy TE
Hematol Oncol Clin North Am; 2016 Feb; 30(1):103-18. PubMed ID: 26614371
[TBL] [Abstract][Full Text] [Related]
40. Everolimus.
Hasskarl J
Recent Results Cancer Res; 2018; 211():101-123. PubMed ID: 30069763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
